drugset / Trial / NCT01089504

Prophylactic Phenobarbital After Neonatal Seizures

NCT01089504

Phase 4 Terminated 13 enrolled University of Rochester
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The treatment of infants with medications after their seizures have stopped is very variable. No one knows if continuing treatment with phenobarbital for up to several months is helpful or harmful. This clinical trial is designed to help answer that question and provide data that will help determine standard of care for these children.

Timeline

Start
2010-09
Primary completion
2014-11
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Phenobarbital Unknown 4 mg/kg Oral
Comparator Phenobarbital Unknown 5 mg/kg Oral